skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Emerging treatment options in bipolar disorderin adolescents: focus on ziprasidone

Review

(2550) Views  (658) Full article downloads

Authors: Afshan A Khan, Jeffrey R Strawn, Paul E Croarkin

Published Date October 2010 Volume 2010:1 Pages 137 - 143
DOI: http://dx.doi.org/10.2147/AHMT.S7586

Afshan A Khan1, Jeffrey R Strawn2, Paul E Croarkin1
1Department of Psychiatry, UT Southwestern Medical Center Dallas, TX, USA; 2Department of Psychiatry, University of Cincinnati, Cincinnati, OH, USA

Abstract: Bipolar disorder is a debilitating, and chronic condition in adolescents. The rate of diagnosis and treatment is increasing in adolescents despite considerable controversy regarding criteria for diagnosis. Atypical antipsychotics have been studied extensively for adult and adolescent bipolar disorder. Ziprasidone is an atypical neuroleptic with novel receptor-binding activity and a favorable side effect profile. It has been marketed in the US since 2000, and now has several indications approved by the US Food and Drug Administration. Emerging case reports, open-label studies, and randomized controlled trials suggest that it may have a role in the management of adolescent bipolar disorder. Somnolence, akathisia, tachycardia, and prolonged corrected QT intervals are major safety concerns. There are no definitive guidelines for dosing ziprasidone in adolescents based on current literature. However, optimal treatment may involve dosages near the adult range. Given minimal data and understanding of its effects on cardiac conduction, it might be prudent to obtain electrocardiograms prior to initiation and during treatment. While not a first-line medication choice for adolescents struggling with bipolar disorder, it may be considered in certain situations in which metabolic side effects and weight gain are of concern.

Keywords: ziprasidone, bipolar disorder, atypical antipsychotics, mood stabilizer, mania, hypomania






Readers of this article also read:

Adolescent insight within the working alliance: A bridge between diagnostic and psychotherapeutic processes
Achieving adolescent adherence to treatment of major depression
Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children
Screening and managing depression in adolescents
Emerging role of aripiprazole for treatment of irritability associated with autistic disorder in children and adolescents
Asthma control in adolescents: role of leukotriene inhibitors
Influencing behavioral change by customer engagement amongst youth
Social capital and risk and protective behaviors: a global health perspective
Anxiety in adolescents: Update on its diagnosis and treatment for primary care providers
Developmental trajectories of overweight and obesity of US youth through the life course of adolescence to young adulthood
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University